These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 21628857)

  • 1. The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia.
    Kwong YL
    J Clin Exp Hematop; 2011; 51(1):21-8. PubMed ID: 21628857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of natural killer-cell malignancies.
    Ishida F; Kwong YL
    Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How we treat NK/T-cell lymphomas.
    Tse E; Zhao WL; Xiong J; Kwong YL
    J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
    Tse E; Kwong YL
    Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas.
    Tse E; Au-Yeung R; Kwong YL
    Expert Rev Hematol; 2019 Nov; 12(11):927-935. PubMed ID: 31487202
    [No Abstract]   [Full Text] [Related]  

  • 7. The diagnosis and management of NK/T-cell lymphomas.
    Tse E; Kwong YL
    J Hematol Oncol; 2017 Apr; 10(1):85. PubMed ID: 28410601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How I treat NK/T-cell lymphomas.
    Tse E; Kwong YL
    Blood; 2013 Jun; 121(25):4997-5005. PubMed ID: 23652805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N; Kato S; Nakamura S
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature.
    Jaccard A; Petit B; Girault S; Suarez F; Gressin R; Zini JM; Coiteux V; Larroche C; Devidas A; Thiéblemont C; Gaulard P; Marin B; Gachard N; Bordessoule D; Hermine O
    Ann Oncol; 2009 Jan; 20(1):110-6. PubMed ID: 18701429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer-cell malignancies: diagnosis and treatment.
    Kwong YL
    Leukemia; 2005 Dec; 19(12):2186-94. PubMed ID: 16179910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK/T-cell lymphomas.
    Tse E; Kwong YL
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):253-261. PubMed ID: 31585625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias.
    Cheung MM; Chan JK; Wong KF
    Semin Hematol; 2003 Jul; 40(3):221-32. PubMed ID: 12876671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type.
    Suzuki R; Suzumiya J; Yamaguchi M; Nakamura S; Kameoka J; Kojima H; Abe M; Kinoshita T; Yoshino T; Iwatsuki K; Kagami Y; Tsuzuki T; Kurokawa M; Ito K; Kawa K; Oshimi K;
    Ann Oncol; 2010 May; 21(5):1032-40. PubMed ID: 19850638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
    Suzuki R
    Int J Hematol; 2010 Dec; 92(5):697-701. PubMed ID: 21116747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal natural killer/T cell lymphoma: we should and we can do more.
    Ying Z; Zhu J
    Chin Clin Oncol; 2015 Mar; 4(1):12. PubMed ID: 25841719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
    Yamaguchi M; Suzuki R; Oguchi M
    Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
    Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
    Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances of treatment for extranodal NK/T-cell lymphoma --- review].
    Zhang SS; Wei M; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1075-8. PubMed ID: 21867647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of advanced NK/T-cell lymphoma.
    Tse E; Kwong YL
    Curr Hematol Malig Rep; 2014 Sep; 9(3):233-42. PubMed ID: 24924658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.